Trial Information

Summary: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.

This clinical study (The Parkinson’s Disease Study) is examining an investigational medication for safety and effectiveness in treating the uncontrolled movements and rigidity ("freezing") that can be caused by levodopa. The investigational drug attempts to block chemicals in the brain that can contribute to movement disorders.

Study inclusion / exclusion criteria

  • At least 30 years old
  • Diagnosed with moderate to severe Parkinson’s disease for at least 5 years
  • On a stable dose of levodopa for at least 2 years
  • Experiencing uncontrolled movements or "freezing" due to levodopa treatment


Contact:

Francisco Grandas, Principal Investigator
Hospital Gregorio Maranon
46 Doctor Esquerdo
Madrid, Spain,
Telephone: 37-91-586-89-99
Fax: 34-91-586-83-39
Email:

 

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 3:26:01 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA